Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Last updated: December 2018
Remove filter for
Last updated: 2018
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 1 of 1 items.
XARELTO (rivaroxaban) - Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement
AlertHealth professional risk communication | 2018-12-20